First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY…
Achieved technical innovation through next-generation carbon black pigment, preventing nozzle clogging even after 40 days of inactivity Reinforced premium brand…
Observance Being Recognized Internationally with Events and Initiatives POTOMAC FALLS, Va., Feb. 19, 2026 /PRNewswire/ — Today, Destinations International (DI), the…